{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:18:39Z","timestamp":1788542319096,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T00:00:00Z","timestamp":1470441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective\/background:<\/jats:title>\n                    <jats:p>\n                      Fluoroquinolones (FQs) are important anti-tuberculous drugs for the treatment of multidrug-resistant (MDR) tuberculosis. Resistance to FQs leads to fewer options for treatment of tuberculosis (TB), and infection with such strains may also require longer treatment duration. Trends of resistance in\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      (MTB) are indicators of MTB-resistance evolution. Drivers of such resistance need to be understood and studied to inform preventive strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Here, we present FQ-resistance rates and trends in Pakistan from 2010 to 2015 and compare rates with FQ-consumption data and rates in other community pathogens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Our results reveal a recent decrease in FQ-resistance rates in MTB, but an increase in resistance for\n                      <jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Shigella<\/jats:italic>\n                      spp. Correlation of FQ resistance with FQ consumption at the population level was weak for MTB, although strong associations were noted for\n                      <jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Shigella<\/jats:italic>\n                      spp.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We discuss the possible reasons for the decrease in resistance rates in TB, putative drivers of resistance other than volume of FQ consumption, and the possible impact of the National Tuberculosis Programme and drug regulatory activities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijmyco.2016.07.008","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T22:09:09Z","timestamp":1471730949000},"page":"412-416","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens"],"prefix":"10.4103","volume":"5","author":[{"given":"S.","family":"Shakoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tahseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20260904","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/598197","article-title":"Fluoroquinolones for treatment of community acquired pneumonia and tuberculosis: putting the risk of resistance into perspective","volume":"48","author":"Low","year":"2009","journal-title":"Clin. Infect. Dis"},{"key":"R2-8-20260904","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijid.2015.01.006","article-title":"Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems","volume":"32","author":"Jabeen","year":"2015","journal-title":"Int. J. Infect. Dis"},{"key":"R3-8-20260904","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","article-title":"The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance","volume":"96","author":"Austin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"R4-8-20260904","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"R5-8-20260904","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3201\/eid1703.100957","article-title":"Fluoroquinoloneresistant Mycobacterium tuberculosis, Pakistan, 2005\u20132009","volume":"17","author":"Jabeen","year":"2011","journal-title":"Emerg. Infect. Dis"},{"key":"R6-8-20260904","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/AAC.00931-10","article-title":"Fluoroquinolone resistance among Mycobacterium tuberculosis strains from Karachi, Pakistan: data from community-based filed clinics","volume":"55","author":"Rafiq","year":"2011","journal-title":"Antimicrob. Agents Chemother"},{"key":"R9-8-20260904","doi-asserted-by":"crossref","first-page":"19241","DOI":"10.1371\/journal.pone.0019241","article-title":"An operational definition of a statistically meaningful trend","volume":"6","author":"Bryhn","year":"2011","journal-title":"PLoS One"},{"key":"R11-8-20260904","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3201\/eid0804.010312","article-title":"Antimicrobial use and antimicrobial resistance: a population perspective","volume":"8","author":"Lipsitch","year":"2002","journal-title":"Emerg. Infect. Dis"},{"key":"R12-8-20260904","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0924-8579(00)00340-X","article-title":"Antibiotic resistance in the absence of selective pressure","volume":"17","author":"Gillespie","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"R13-8-20260904","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1128\/AAC.02066-13","article-title":"High proportion of heteroresistance in gyrA and gyrB in fluoroquinoloneresistant Mycobacterium tuberculosis clinical isolates","volume":"58","author":"Eilertson","year":"2014","journal-title":"Antimicrob. Agents Chemother"},{"key":"R14-8-20260904","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/jac\/dki353","article-title":"Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995\u20132003","volume":"56","author":"Huang","year":"2005","journal-title":"J. Antimicrob. Chemother"},{"key":"R15-8-20260904","doi-asserted-by":"crossref","first-page":"654","DOI":"10.5588\/ijtld.14.0751","article-title":"Can the number of patients with presumptive tuberculosis lost in the general health services in Pakistan be reduced?","volume":"19","author":"Fatima","year":"2015","journal-title":"Int J. Tuberc. Lung Dis"},{"key":"R16-8-20260904","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.14.0001","article-title":"Success of active tuberculosis case detection among high-risk groups in urban slums in Pakistan","volume":"18","author":"Fatima","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2212553116300632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2212553116300632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/01929415-201605040-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:01:42Z","timestamp":1788541302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01929415-201605040-00008"}},"subtitle":["Ecological antibiotic pressure and consequences in Pakistan, 2009\u20132015"],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijmyco.2016.07.008","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}